nach oben

Die Diabetologie

Erschienen in:

29.06.2021 | Typ-2-Diabetes | Im Fokus

Diabetes Update 2021

Neue Erkenntnisse auf dem Gebiet des Diabetes mellitus

verfasst von: Univ.-Prof. Dr. med. Werner Scherbaum

Erschienen in: Die Diabetologie | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Auszug

Herr Prof. Dr. Stefan Martin vom Verbund Katholischer Kliniken und Westdeutschen Diabetes- und Gesundheitszentrum in Düsseldorf richtete die Aufmerksamkeit auf neue Studien zum Einfluss von Ernährungsfaktoren und Lebensstil auf die Insulinempfindlichkeit und die Diabetesprävention. …

Chazelas E, Debras C, Srour B et al (2020) Sugary drinks, artificially sweetened beverages, and cardiovascular diseases in the NutriNet-Santé Cohort. J Am Coll Cardiol 78(18):2175–2177CrossRef

Dalenberg JR, Patel PB, Denis R et al (2020) Short-term consumption of Sucralose with, but Not without, carbohydrate impairs neural and metabolic sensitivity to sugar in humans. Cell Metab 31(3):493–502.e7CrossRef

Taheri S, Zaghloul H, Chagoury O et al (2020) Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised, controlled trial. Lancet Diabetes Endocrinol 8(6):477–489CrossRef

Halle M, Röhling M, Banzer W et al (2020) ACOORH study group. Meal replacement by formula diet reduces weight more than a lifestyle intervention alone in patients with overweight or obesity and accompanied cardiovascular risk factors—the ACOORH trial. Eur J Clin Nutr 75:661–669CrossRef

ACOOH Study Group, Röhling M, Kempf K, Banzer W et al (2020) Prediabetes conversion to normoglycemia is superior adding a low-carbohydrate and energy deficit formula diet to lifestyle intervention—A 12-month subanalysis oft he ACOORH trial. Nutrients 12(7):2022. https://doi.org/10.3390/nu12072022CrossRef

Yoshino M, Kayser BD, Yoshino J et al (2020) Effects of diet versus gastric bypass on metabolic function in diabetes. N Engl J Med 383:721–732CrossRef

Wilding PH, Batterham RL, Calanna S et al (2021) Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med 384:989–1002CrossRef

Wadden TA, Bailey TS, Billings KL et al (2021) Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity. JAMA. https://doi.org/10.1001/jama.2021.1831CrossRefPubMed

Bergenstal R, Nimri R, Beck RW et al (2021) A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial. Lancet 397:208–219CrossRef

10.

Brenton MD, Kanapka LG, Beck RW et al (2020) A randomized trial of closed-loop control in children with type 1 diabetes. N Engl J Med 383:836–845CrossRef

11.

Sherr JL, Buckinham BA, Forlenza GP et al (2020) Safety and performance of the Omnipod Hybrid-Closed-Loop system in adults, adolescents, and children with type 1 diabetes over 5 days under free-living conditions. Diabetes Technol Ther 22:174–184CrossRef

12.

Breton MD et al. N Engl J Med 202383:836–845–219

13.

Allotey J, Stallings E, Bonet M et al (2020) Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 370:m3320. https://doi.org/10.1136/bmj.m3320CrossRefPubMed

14.

Metz TD, Clifton RG, Hughes BL et al (2021) Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19). Obstet Gynecol 137:571CrossRef

15.

Kleinwechter H (2020) SARS-CoV-2-Infektion/COVID-19. Schwangerschaft und Diabetes. Stand 15. Dezember 2020 aus diabetologischer Perspektive. In[Fo]Diabetologie 15:34–41

16.

Gray KJ, Bordt EA, Atyeo C et al (2021) COVID-19 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol. https://doi.org/10.1016/j.ajog.2021.03.023CrossRefPubMedPubMedCentral

17.

Shimabukuro TT, Sy K, Myers TR et al (2021) Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med 384:2273–2282CrossRef

18.

Wu X, Liu B, Sun Y et al (2020) Association of maternal pregnancy diabetes and gestational diabetes mellitus with congenital anomalites of the newborn. Diabetes Care 43(1):2983–2990CrossRef

19.

Tinker S, Gilboa S, Moore C et al (2020) Specific birth defects in pregnancies of women with diabetes. National Birth Defects Prevention Study, 1997–2011. Am J Obstet Gynecol. https://doi.org/10.1016/J.ajog.2019.08.028CrossRefPubMed

20.

Feig D, Donovan L, Zinman B et al (2020) Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol 8:834–844CrossRef

21.

Hochlenert D, Fischer C (2020) Ventral windowed total contact casts safely offload diabetic feet and allow access to the foot. J Diabetes Sci Technol. https://doi.org/10.1177/1932296820964069CrossRefPubMed

22.

Potier L, François M, Dardari D et al (2020) Comparison of a new versus standard removable offloading device in patients with neuropathic diabetic foot ulcers: a French national multicentre, open-label randomized, controlled trial. BMJ Open Diabetes Res Care. https://doi.org/10.1136/bmjdrc-2019-000954CrossRefPubMedPubMedCentral

23.

Spraul AMS, Schönbach AM, Müller N et al (2020) Long-term outcome of persons with diabetic and non-diabetic neuroosteoarthropathy after foot correction using external fixation. Diabet Med. https://doi.org/10.1111/dme.14404CrossRefPubMed

24.

Näslund J, Hieronymus F, Lisinski A et al (2018) Effects of selective serotonin reuptake inhibitors on rating-scale-assessed suicidality in adults with depression. Br J Psychiatry 212(3):148–154CrossRef

25.

Martorell AJ, Paulson AL, Suk HJ et al (2019) Multy-sensory gamma stimulation ameliorates Alzheimer’s-associated pathology and improves cognition. Cell 177(2):256–271.e22CrossRef

26.

Iaccario HF, Singer AC, Martorell AJ et al (2018) Gamma frequency entrainment attenuates amyloid load and modifies microgla. Nature 540(7632):230–235CrossRef

27.

Packer M, Anker S, Butler J et al (2020) Cardiovascular and renal outcomes with Empagliflozin in heart failure. N Eng J Med 383:1413–1424CrossRef

28.

Jercho JA (2020) More evidence for SGLT2-Inhibitors in heart failure. N Eng J Med 383:1481–1482CrossRef

29.

Bhatt DL, Szarek M, Steg PG et al (2021) Sotagliflozin in patients with diabetes and recent worsening of heart faikure. N Eng J Med 384(2):117–128CrossRef

30.

Gencer B, Marston NA, Im KA et al (2020) Efficacy and safety of lowering LDL Cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials. Lancet 396(102639):1637–1643CrossRef

31.

Orkaby AR, Driver JA, Ho Y‑L et al (2020) Association of statin use with all-cause and cardiovascular mortality in US veterans 75 years and older. JAMA 324(1):68–78CrossRef

32.

Ray KK, Wright RC, Kallend D et al (2020) Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol. N Engl J Med 382(16):1507–1519CrossRef

33.

Bahrmann A, Bahrmann P, Baumann J et al (2018) S2k-Leitlinie Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Alter, AWMF-Register-Nr.: 057-017. Diabetes Stoffwechs 13:423–492CrossRef

34.

Quaseem A, Wilt TJ, Kansagara D et al (2018) Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: A guidance statement update from the American College of Physicians. Ann Intern Med 168(8):569–576CrossRef

35.

Zeyfang A, Bahrmann A, Wernecke J (2020) Praxisempfehlungen der Deutschen Diabetes Gesellschaft: Diabetes mellitus im Alter. Diabetologie 15(Suppl 1):112–119

36.

Palmer C, Tendal B, Mustafa RA et al (2021) Sodium-glucose cotransporter protein‑2 (SGLT-2) inhibitors and glucagon-like peptide‑1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials. BMJ 372:m4573CrossRef

37.

Gerstein HC, Hart R, Colhoun HM et al (2020) The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial. Lancet Diabetes Endocrinol 8(2):106–114CrossRef

38.

Amerenco P, Kim JS, Labreuche J et al (2020) A comparison of two LDL cholesterol targets after ischaemic stroke. N Engl J Med 382:9–19CrossRef

39.

Koromani F, Oel L, Shevroja L et al (2020) Vertebral fractures in individuals with type 2 diabetes: more than skeletal complications alome. Diabetes Care 43(1):137–144CrossRef

40.

Vilaca T, Schini M, Harnan S et al (2020) The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: a systematic review and meta-analysis update. Bone 137:115457CrossRef

41.

Liu H, Yoshida K, Zhao SS et al (2020) Delayed denosumab injections and fracture risk among patients with osteoporosis: a population-based cohort study. Ann Intern Med 173(7):516–526CrossRef

42.

Tsourdi E, Zillikens MC, Meier C et al (2021) Fracture risk and management of discontinuation of Denosuab therapy: a systematic review and position statement by ECTS. J Clin Endocrinol Metab 106(1):264–281CrossRef

43.

Pang X, Pu T, Xu L et al (2020) Effect of L‑thyroxine administration before breakfast vs at bedtime on hypothyroidism. A meta-analysis. Clin Endorinol 92(5):475–481CrossRef

Titel: Diabetes Update 2021
Neue Erkenntnisse auf dem Gebiet des Diabetes mellitus
verfasst von: Univ.-Prof. Dr. med. Werner Scherbaum
Publikationsdatum: 29.06.2021
Verlag: Springer Medizin
Schlagwort: Typ-2-Diabetes
Erschienen in: Die Diabetologie / Ausgabe 5/2021
Print ISSN: 2731-7447
Elektronische ISSN: 2731-7455
DOI: https://doi.org/10.1007/s11428-021-00782-4

Praxisempfehlungen der Deutschen Diabetes Gesellschaft

Kurz, prägnant und aktuell: Die Praxisempfehlungen der Deutschen Diabetes Gesellschaft.

Zu den Praxisempfehlungen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2021

Diabetes und Schwangerschaft

Gesundheits-Pass Diabetes

Update Typ-2-Diabetes

Herzinsuffizienz bei Menschen mit Diabetes mellitus

Diabetes Update 2021

Für Sie kommentiert: neue Studien zu Hypertonie und Diabetes

Praxisempfehlungen der Deutschen Diabetes Gesellschaft